Skip to content
Go to home page
Join
  1. Home
  2. News and press releases
  3. Cancer Crosslinks 2025: a photo gallery

Cancer Crosslinks 2025: a photo gallery

Scroll through images from this year’s Cancer Crosslinks, a full-day educational programme and networking event tailored to the oncology community.

A panel discussion at a professional conference features six individuals standing around two tall tables with small potted plants. The central speaker, a man in a black suit and red tie, gestures while speaking, as the other panelists attentively listen. The background displays a large screen with partially visible text, including the names "Hanne Mari Hamre" and a blue banner with the words "FROM CANCER." The panelists wear lanyards with name tags, indicating their participation in the event. The setting is a well-lit stage with a professional and formal atmosphere.
Speakers conversed on stage on how to break down silo-thinking to advance cancer research. Photo: Åsmund Groven

Want to learn more about Cancer Crosslinks? Please visit: https://www.cancercrosslinks.com/

Published

Jan 28, 2025

Author

Sofia Linden

Category
Event

The 17th Cancer Crosslinks was held at Oslo Cancer Cluster Innovation Park last Thursday. This year's edition brought the focus on how innovations in basic research, translational research and technology can improve cancer patients' lives.

A group photo of diverse professionals at the Cancer Crosslinks 2025 event, standing on a stage with a large screen in the background displaying the event's name and tagline: "Bridging Innovations to Improve Clinical Outcomes for Cancer Patients." The attendees, wearing business attire and blue lanyards, are smiling for the camera. The stage is flanked by two blue banners that read "From Cancer Research to Cure" and "Oslo Cancer Cluster." The setting is a formal conference environment, emphasizing collaboration in cancer research and innovation.
The speakers of Cancer Crosslinks 2025 included renowned cancer researchers from the US, UK and Nordics, and the moderators represented prominent Norwegian scientists. Here pictured with the Oslo Cancer Cluster organising team and the sponsors Bristol-Myers Squibb and Kite (a Gilead company). Photo: Åsmund Groven

Distinguished speakers from the UK, US, and the Nordics addressed emerging diagnostic and treatment options for solid and haematological cancers. The topics of the educational talks ranged from developments in tumour-agnostic therapies and precision medicine, to improvements in cell therapy and recent digital innovations.

Marine Jeanmougin, Lead EU Affairs and Digital Innovations at Oslo Cancer Cluster, commented:

“We see cancer differently and treat it differently than we did ten years ago, as Magnus Essand stated during his talk, capturing the essence of Cancer Crosslinks 2025. This was further illustrated by Vivek Subbiah, Ruth Plummer, and Inge Marie Svane, who showed how advances in molecular biology and immunology are driving innovative cancer treatments.

“With upcoming digital solutions and data-sharing infrastructures, more changes are on the horizon, as Ingrid Stenstadvold Ross and Joel Hedlund pointed out. The next decade offers unique opportunities in cancer care, and we will continue to use Cancer Crosslinks as a forum for learning and collaboration.”

A networking break at a professional conference shows a large group of attendees, many wearing blue lanyards with name tags, gathered around a buffet table with pastries, bread, and bowls of food. People are engaged in conversation while others wait in line to get refreshments. The setting is a bright indoor conference venue with modern architecture, featuring large windows, white pillars, and greenery in the background. The atmosphere is lively, with participants interacting and enjoying the break.
The networking breaks were buzzing with activity as attendees connected with colleagues in the oncology community. Photo: Åsmund Groven

The event attracted approximately 300 attendees who wanted to learn the latest from the international cancer research front. Academics, clinicians, patient spokespeople, health bureaucrats and industry representatives from different parts of Norway and abroad were among the participants.

Charlotte Wu Homme, Head of Membership and Events at Oslo Cancer Cluster, commented:

“Oslo Cancer Cluster (OCC) is a membership organization dedicated to improving the lives of cancer patients. Cancer Crosslinks is one way OCC contributes towards knowledge-sharing and collaboration in oncology.

“I would like to thank the many OCC members and fellow stakeholders who joined us last week. Your participation strengthens our ecosystem. A special acknowledgement to OCC Members BMS and Kite, A Gilead Company for sponsoring this event, helping to make a meeting at this scale, possible.”

A man and a woman on stage at the Cancer Crosslinks 2025 event, both wearing blue lanyards and presenting to an audience. The man, wearing a patterned shirt and glasses, gestures with his hand while holding a piece of paper. The woman, dressed in dark clothing, listens attentively while holding a notepad. Behind them, a large screen displays text mentioning the Norwegian University of Science and Technology (NTNU) and St. Olav’s Hospital. The stage is framed by blue banners with the phrase "From Cancer Research to Cure," emphasizing the event’s focus on oncology and medical innovation.
Åsmund Flobak and Else Marit Inderberg represented the academic milieus at St Olav Hospital/NTNU in Trondheim and Oslo University Hospital as moderators at Cancer Crosslinks 2025. Photo: Åsmund Groven
A speaker at the Oslo Cancer Cluster event, standing behind a podium with the organization's logo. He is wearing a dark suit, a blue lanyard, and a red tie, smiling as he addresses the audience. A can of water is placed on the podium. Behind him, a large presentation slide is projected, displaying medical research details, including references to adenocarcinoma of the small intestine, clinical trial endpoints, and a mention of Vivek Subbiah on social media. The blue banners on the stage read "From Cancer Research to Cure," highlighting the focus of the event.
Vivek Subbiah​, MD, Chief, Early-Phase Drug Development, Sarah Cannon Research Institute (SCRI), Nashville, USA held the keynote speech titled "Revolutionizing Cancer Therapy: ​Breaking Barriers in Oncology with Tumor-Agnostic Drug Development". Photo: Åsmund Groven
A speaker at the Cancer Crosslinks event, identified as Ruth Plummer, is addressing the audience from behind a podium. She is wearing a dark blue sweater and a lanyard, with a microphone headset attached. The background features a blue-lit banner with the phrase "From Cancer Research to Cure," along with green plants, contributing to the professional and engaging atmosphere of the conference.
Ruth Plummer, Clinical Professor of Experimental Cancer Medicine, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, ​Director of Sir Bobby Robson Cancer Trials Research Centre, Newcastle, UK put a focus on personalised treatment in her presentation "Can precision medicine deliver histology-independent drug discovery?". Photo: Åsmund Groven
Magnus Essand is delivering a presentation at the Cancer Crosslinks event, standing behind a white podium with his name displayed. He is wearing a dark suit, white shirt, and a red pocket square, gesturing with one hand while holding a presentation remote in the other. The background features a blue-lit banner with the words "From Cancer Research to Cure," alongside green plants, reinforcing the conference’s focus on cancer research and innovation.
Magnus Essand, Professor of Gene Therapy, Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden, highlighted CAR T cell therapy as a potential treatment against glioblastoma in his talk "Arming CAR-T cells for potent bystander immune response in lymphoma and glioblastoma". Photo: Åsmund Groven
Inge Marie Svane, Professor, MD, PhD, is delivering a presentation at the Cancer Crosslinks event. She stands behind a white podium with her name displayed, smiling while speaking into a headset microphone. The background features a large screen displaying her credentials, including her role as Director of the National Center for Cancer Immune Therapy at Copenhagen University Hospital, Herlev, Denmark. The event setting includes blue banners with the text "From Cancer Research to Cure," reinforcing the focus on oncology and cancer treatment advancements. A water bottle is placed on the podium.
Inge Marie Svane, Professor, MD, Director, National Center for Cancer Immune Therapy – CCIT-DK, Department of Oncology, Herlev Hospital, Copenhagen University, Denmark gave updates on using T cell therapy to treat advanced skin cancer in the presentation "Prime time for adoptive T-cell therapy for metastatic melanoma". Photo: Åsmund Groven
A woman in a black blazer and dress stands on stage at the Cancer Crosslinks event, holding a notepad while speaking. She is smiling and looking towards the audience, wearing a blue lanyard with a name badge. The background features a large screen, blue banners with the text "From Cancer Research to Cure," and stage lighting. A podium with a nameplate is visible in the foreground, partially cut off, with a water bottle placed on top. A potted plant adds a decorative touch to the stage setting.
​Ingrid Stenstadvold Ross, Secretary General, Norwegian Cancer Society, talked about how digital innovations can transform the cancer patient journey. Photo: Åsmund Groven
A bald man with a beard, identified as Joel Hedlund, stands behind a podium at the Cancer Crosslinks event, delivering a presentation. He is dressed in a dark suit with a pocket square and is gesturing with his right hand while holding a remote control. Behind him, a large screen displays a slide featuring a map, bullet points about AI in clinical research, and collaboration between healthcare, industry, and academia. The audience in the foreground is seen taking notes and working on laptops. The event branding, including blue banners with the phrase "From Cancer Research to Cure," is visible on the stage. A potted plant adds greenery to the setting.
Joel Hedlund, PhD, Data Director Center for Medical Image Science and Visualization (CMIV)/Analytic Imaging Diagnostics Arena (AIDA), ​AIDA Data Hub Lead, Linköping University, Sweden, introduced AIDA - A national collaboration arena for clinical innovation in medical imaging diagnostics AI. Photo: Åsmund Groven

Similar articles

Cancer Crosslinks 2025: a photo gallery